FDA Import Refusal 1FX-0455126-4/20002/1 — Cipla Pvt Ltd
The FDA refused shipment 1FX-0455126-4/20002/1 from Cipla Pvt Ltd (India) on Aug 25, 2026. The refused product falls under Drugs and Biologics — BUDESONIDE (ANTI-ASTHMATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 25, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61ECY04 BUDESONIDE (ANTI-ASTHMATIC)
- Charges
- 75